Search Within

Sarah E Stump

Formats
  1. Journal Article (8)
  2. Meeting Abstract (2)
  3. Review (2)
Groups
  1. Adult Leukemia (6)
  2. Center for Hematologic Malignancies (6)
  3. Clinical Pharmacy Specialists (6)
  4. Department of Medicine (6)
  5. Hematologic Malignancies, Division of (6)
  6. Department of Pathology and Laboratory Medicine (2)

More Groups

People
  1. Charlene Kabel (5)
  2. Ryan Daley (4)
  3. Taylor Weis (4)
  4. Martin Tallman (3)
  5. Amber King (2)
  6. Anthony Mato (2)

More People

Years
  1. 2023 (2)
  2. 2022 (4)
  3. 2021 (1)
  4. 2020 (2)
  5. 2019 (3)
Publications
  1. Leukemia and Lymphoma (4)
  2. Blood (2)
  3. Journal of Oncology Pharmacy Practice (2)
  4. Annals of Pharmacotherapy (1)
  5. Blood Advances (1)
  6. International Journal of Hematology (1)

More Publications

Publishers
  1. Taylor & Francis Group (4)
  2. American Society of Hematology (3)
  3. Sage Publications Ltd. (2)
  4. Elsevier Ltd (1)
  5. Sage Publications (1)
  6. Springer Japan KK (1)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia
    Journal Article

    Shinn, L. T.; Benitez, L. L.; Perissinotti, A. J.; Reid, J. H.; Buhlinger, K. M.; van Deventer, H.; Barth, D.; Wagner, C. B.; Zacholski, K.; Desai, R.; more...
    International Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia
    Journal Article

    Atchley, E.; Weis, T. M.; Derkach, A.; Galera, P. K.; Xiao, W.; Glass, J.; DeWolf, S.; Roshal, M.; Shah, R.; Stump, S. E.
    Leukemia Research (2023)

    Fulltext@MSK | Save
  • Real-world management of targeted therapies in chronic lymphocytic leukemia
    Review

    Weis, T. M.; Gutierrez, J.; Kabel, C. C.; King, A. C.; Daley, R. J.; Stump, S. E.
    Journal of Oncology Pharmacy Practice (2022)

    Fulltext@MSK | Save
  • Multicenter comparison of first salvage chemotherapy versus novel therapy regimens in adult relapsed/refractory acute lymphoblastic leukemia
    Journal Article

    Ochs, M. A.; Marini, B. L.; Benitez, L. L.; Stump, S. E.; Weis, T. M.; Buhlinger, K. M.; Diaz, T.; Reid, J. H.; Muluneh, B.; Pettit, K.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Impact of adherence to ibrutinib on clinical outcomes in real-world patients with chronic lymphocytic leukemia
    Journal Article

    Collins, J. 4th; Stump, S. E.; Heiling, H.; Muir, M.; Deal, A.; Proco, D.; Nguyen, C.; Cozad, M.; Mato, A.; Coombs, C. C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Evaluation of an interdisciplinary venetoclax initiation process in minimizing risk of tumor lysis syndrome
    Journal Article

    Cozad, M.; Stump, S. E.; Buhlinger, K.; Collins, J. 4th; Muir, M.; Coombs, C. C.; Muluneh, B.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia
    Journal Article

    Daley, R. J.; Rajeeve, S.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Lavery, J. A.; Tallman, M. S.; Geyer, M. B.; Park, J. H.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN
    Journal Article

    Xiao, W.; Miles, L. A.; Bowman, R. L.; Durani, V.; Tian, H. S.; DelGaudio, N. L.; Mishra, T.; Zhu, M.; Zhang, Y.; Stump, S. E.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Evaluation of mobilization efficacy with an extended interval following plerixafor administration
    Journal Article

    Stump, S. E.; Trepte, M.; Shaw, J. R.; Grgic, T.; Ptachcinski, J. R.; Sharf, A.; Riches, M.; Shea, T. C.; Park, Y. A.; Alexander, M. D.
    Journal of Oncology Pharmacy Practice (2020)

    Fulltext@MSK | Save
  • Toxicities and outcomes of acalabrutinib-treated patients with chronic lymphocytic leukemia: A retrospective analysis of real world patients
    Meeting Abstract

    Yazdy, M. S.; Mato, A. R.; Roeker, L. E.; Jarral, U.; Ujjani, C. S.; Shadman, M.; Skarbnik, A.; Whitaker, K. J.; Deonarine, I.; Kabel, C. C.; more...
    Blood (2019)

    Fulltext@MSK | Save